JPMorgan Chase & Co’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.4M | Buy |
3,086,779
+555,466
| +22% | +$5.29M | ﹤0.01% | 1491 |
|
|
2025
Q1 | $26.5M | Buy |
2,531,313
+2,432,926
| +2,473% | +$25.4M | ﹤0.01% | 1517 |
|
|
2024
Q4 | $2.32M | Sell |
98,387
-3,363
| -3% | -$79.2K | ﹤0.01% | 3293 |
|
|
2024
Q3 | $3.65M | Buy |
101,750
+4,236
| +4% | +$152K | ﹤0.01% | 2831 |
|
|
2024
Q2 | $3.44M | Buy |
97,514
+43,144
| +79% | +$1.52M | ﹤0.01% | 2752 |
|
|
2024
Q1 | $1.54M | Buy |
54,370
+12,887
| +31% | +$366K | ﹤0.01% | 3312 |
|
|
2023
Q4 | $552K | Sell |
41,483
-296,691
| -88% | -$3.95M | ﹤0.01% | 3850 |
|
|
2023
Q3 | $3.03M | Buy |
338,174
+302,562
| +850% | +$2.71M | ﹤0.01% | 2739 |
|
|
2023
Q2 | $401K | Buy |
35,612
+8,743
| +33% | +$98.4K | ﹤0.01% | 3878 |
|
|
2023
Q1 | $309K | Buy |
26,869
+6,425
| +31% | +$73.9K | ﹤0.01% | 4078 |
|
|
2022
Q4 | $237K | Sell |
20,444
-23,332
| -53% | -$270K | ﹤0.01% | 4129 |
|
|
2022
Q3 | $557K | Buy |
43,776
+8,456
| +24% | +$108K | ﹤0.01% | 3680 |
|
|
2022
Q2 | $242K | Buy |
35,320
+7,462
| +27% | +$51.1K | ﹤0.01% | 4230 |
|
|
2022
Q1 | $268K | Sell |
27,858
-9,980
| -26% | -$96K | ﹤0.01% | 4296 |
|
|
2021
Q4 | $450K | Sell |
37,838
-55,845
| -60% | -$664K | ﹤0.01% | 4132 |
|
|
2021
Q3 | $1.52M | Buy |
93,683
+77,835
| +491% | +$1.26M | ﹤0.01% | 3334 |
|
|
2021
Q2 | $334K | Buy |
15,848
+5,679
| +56% | +$120K | ﹤0.01% | 4224 |
|
|
2021
Q1 | $158K | Buy |
10,169
+3,789
| +59% | +$58.9K | ﹤0.01% | 4530 |
|
|
2020
Q4 | $134K | Buy |
+6,380
| New | +$134K | ﹤0.01% | 4247 |
|